comparemela.com

Latest Breaking News On - Theo vos - Page 1 : comparemela.com

Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China

AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical.

Long COVID is a double curse in low-income nations — here s why

Not only is the prevalence of the condition poorly understood, but it’s also often ignored by physicians and the wider public. Not only is the prevalence of the condition poorly understood, but it’s also often ignored by physicians and the wider public.

Preparing for the Next Pandemic—and the Next Season of Pandemic Proof

The investment case for bolstering global systems for pandemic preparedness and response is clear. Yet, COVID-19 exposed gaping holes in our collective ability to respond to pandemic threats. And even after more than 6.9 million deaths from COVID-19 and trillions in economic losses, financing and policy arrangements for preparedness remain insufficient. Policymakers still need to reckon with the lessons learned during recent outbreaks to ensure stronger systems going forward.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.